• Georgios Krommidas, Konstantinos Kostikas, Georgios Papatheodorou, Agela Koutsokera, Konstantinos I Gourgoulianis, Charis Roussos, Nikolaos G Koulouris, and Stelios Loukides.
• 1st Respiratory Medicine Department, University of Athens Medical School, Mesogeion 152 15669 Athens Greece. geokrommidas@yahoo.gr
• Respir Med. 2010 Jan 1; 104 (1): 40-6.

BackgroundVarious systemic inflammatory markers have been evaluated for their value in acute exacerbations of chronic obstructive pulmonary disease (COPD). Leptin and adiponectin have been linked to acute exacerbations and stable COPD.ObjectivesTo assess plasma leptin, adiponectin and their ratio in acute exacerbations of COPD and to study possible associations with inflammatory biomarkers.MethodsPlasma leptin, adiponectin and their ratio (L/A) and serum biomarkers of systemic inflammation C-reactive protein (CRP), Tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) were assessed at three time points (admission, resolution and stable phase - 8 weeks after resolution) in a selected cohort of 63 COPD patients hospitalized for acute exacerbations. Subjects with comorbidities related to adipose tissue hormones were meticulously excluded.Measurements And Main ResultsAll systemic inflammatory biomarkers, leptin and L/A ratio were elevated during admission compared to resolution and stable phase (mean L/A ratio 2.6 vs. 1.57 vs. 1.22, respectively; p<0.0001), whereas adiponectin was elevated at resolution compared to admission. Log leptin, adiponectin and L/A ratio were significantly associated with variables of systemic inflammation, after proper adjustments, both on admission and in stable condition. In stepwise multiple linear regression models, IL-6 and TNF-alpha present the most significant associations with leptin, adiponectin and their ratio.ConclusionsOur data suggest that both leptin and adiponectin are associated with the systemic inflammatory process during exacerbations of COPD. The most significant associations seem to be those with IL-6 and TNF-alpha.Copyright 2009 Elsevier Ltd. All rights reserved.

22 keywords...

hide…